Heidi Olzscha

1.6k total citations · 1 hit paper
15 papers, 1.0k citations indexed

About

Heidi Olzscha is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Heidi Olzscha has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Neurology. Recurrent topics in Heidi Olzscha's work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (4 papers). Heidi Olzscha is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (4 papers). Heidi Olzscha collaborates with scholars based in United Kingdom, Germany and South Korea. Heidi Olzscha's co-authors include Nicholas B. La Thangue, Maria I. New, F. Ulrich Hartl, R. Martin Vabulas, Michele Vendruscolo, Stefan Pinkert, Michael H. Hecht, Gian Gaetano Tartaglia, Andreas C. Woerner and Manajit Hayer‐Hartl and has published in prestigious journals such as Cell, Blood and Cancer Research.

In The Last Decade

Heidi Olzscha

15 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions

2011 541 citations Heidi Olzscha, Andreas C. Woerner et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi Olzscha United Kingdom	9	847	200	199	136	123	15	1.0k
Eileen J. Kennedy United States	19	894 1.1×	102 0.5×	157 0.8×	110 0.8×	123 1.0×	55	1.2k
Mathieu Lavallée‐Adam Canada	21	1.1k 1.3×	168 0.8×	279 1.4×	115 0.8×	86 0.7×	47	1.6k
Jack M. Webster United States	20	770 0.9×	106 0.5×	197 1.0×	204 1.5×	205 1.7×	32	1.3k
Francesca Vallese Italy	19	687 0.8×	206 1.0×	163 0.8×	148 1.1×	33 0.3×	36	1.1k
Roberto Bresciani Italy	19	919 1.1×	278 1.4×	372 1.9×	88 0.6×	91 0.7×	52	1.3k
Jeffrey N. Higaki United States	18	752 0.9×	348 1.7×	174 0.9×	213 1.6×	213 1.7×	33	1.2k
Alex M. Jaeger United States	17	973 1.1×	114 0.6×	303 1.5×	170 1.3×	225 1.8×	20	1.3k
Gopal Gunanathan Jayaraj India	16	1.0k 1.2×	166 0.8×	278 1.4×	63 0.5×	36 0.3×	17	1.3k
Victoria Menéndez-Benito Sweden	14	898 1.1×	86 0.4×	323 1.6×	95 0.7×	134 1.1×	16	1.1k
Uwe Bertsch Germany	22	1.0k 1.2×	144 0.7×	98 0.5×	37 0.3×	80 0.7×	36	1.2k

Countries citing papers authored by Heidi Olzscha

Since Specialization

Citations

This map shows the geographic impact of Heidi Olzscha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Olzscha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Olzscha more than expected).

Fields of papers citing papers by Heidi Olzscha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Olzscha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Olzscha. The network helps show where Heidi Olzscha may publish in the future.

Co-authorship network of co-authors of Heidi Olzscha

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Olzscha. A scholar is included among the top collaborators of Heidi Olzscha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Olzscha. Heidi Olzscha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Bork, Kaya, et al.. (2022). Disturbance of Key Cellular Subproteomes upon Propofol Treatment Is Associated with Increased Permeability of the Blood-Brain Barrier. Proteomes. 10(3). 28–28. 3 indexed citations

2.

Bork, Kaya, et al.. (2020). Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells. Journal of Visualized Experiments. 5 indexed citations

3.

Bork, Kaya, et al.. (2020). Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells. Journal of Visualized Experiments. 1 indexed citations

4.

Olzscha, Heidi, et al.. (2020). Glycation Increases the Risk of Microbial Traversal through an Endothelial Model of the Human Blood-Brain Barrier after Use of Anesthetics. Journal of Clinical Medicine. 9(11). 3672–3672. 8 indexed citations

5.

Olzscha, Heidi, et al.. (2020). Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease. Frontiers in Cell and Developmental Biology. 8. 425–425. 31 indexed citations

6.

Olzscha, Heidi. (2019). Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated. Biological Chemistry. 400(7). 895–915. 40 indexed citations

7.

New, Maria I., Heidi Olzscha, Marie‐Laëtitia Thézénas, et al.. (2016). TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism. Cancer Research. 76(23). 6975–6987. 31 indexed citations

8.

Olzscha, Heidi, et al.. (2016). HDAC Inhibitors. Methods in molecular biology. 1436. 281–303. 12 indexed citations

9.

Olzscha, Heidi, Oleg Fedorov, Benedikt M. Kessler, Stefan Knapp, & Nicholas B. La Thangue. (2016). CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation. Cell chemical biology. 24(1). 9–23. 31 indexed citations

10.

New, Maria I., et al.. (2016). The TLR Adaptor Protein MyD88 Mediates Cell Sensitivity to HDAC Inhibitors through a Cytokine-Dependent Mechanism. Blood. 128(22). 1766–1766. 1 indexed citations

11.

Olzscha, Heidi, et al.. (2014). Deacetylation of Chromatin and Gene Expression Regulation: A New Target for Epigenetic Therapy. Critical Reviews™ in Oncogenesis. 20(1-2). 1–17. 35 indexed citations

12.

New, Mark, Heidi Olzscha, Geng Liu, et al.. (2013). A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors. Cell Death and Differentiation. 20(10). 1306–1316. 37 indexed citations

13.

Olzscha, Heidi, Maria I. New, & Nicholas B. La Thangue. (2013). Clinical Exemplification of HDAC Inhibitors: From Bench to Clinic, and Back Again. 1(3). 75–84. 1 indexed citations

14.

New, Maria I., Heidi Olzscha, & Nicholas B. La Thangue. (2012). HDAC inhibitor‐based therapies: Can we interpret the code?. Molecular Oncology. 6(6). 637–656. 263 indexed citations

15.

Olzscha, Heidi, Andreas C. Woerner, Stefan Pinkert, et al.. (2011). Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions. Cell. 144(1). 67–78. 541 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact